Our complex adult brain is able to make the daily connections between areas to present appropriate behavior in response to our environment. The higher cognitive functions include perception, attention, memory, problem solving, and emotion, and involves appropriate cross-talk between neuronal subpopulations in various brain regions. The development of these brain areas is a multi-step process that includes proliferation, migration, axon guidance, dendritic arborization, and synaptogenesis to establish the correct maturation of the areas and their connectivity. The various steps in brain area development are guided by a plethora of molecules that are expressed at a particular place at a specific time. To decipher the exact developmental mechanisms that underlie the etiology of neurodevelopmental disorders, it is necessary to unravel the function of these molecules in four dimensions.

Linkage and association studies have classified multiple candidate genes that might contribute to the clinical features of neurodevelopmental disorders. Many of them seem to be involved in the neurodevelopmental events of brain maturation. Their exact functions over time and in relation to other genes, however, remain elusive. Animal models provide compelling insight into cognitive endophenotypes of these disorders by unraveling the underlying biological mechanism of the disease (Gould and Gottesman, [@B13]; Kellendonk et al., [@B18]). By introducing molecular fluorescent control and gene target constructs, we are now able to monitor the mechanisms of (mis)development. Traditionally, the gene of interest would be molecularly targeted by homologous recombination, resulting in a systemic absence of the gene in the animal. However, besides a high level of variability in the knockout and transgenic lines, often molecular compensation mechanisms occur. Further, the molecular alteration in the complete organism shows low construct validity in these complex disorders and even in a Cre--Lox system a large part of the brain is targeted. For this reason, the innovative and exciting technique of *in utero* electroporation (IUE)-mediated gene transfer is a huge step forward in the research of biological functions of genes over time, especially in the study of psychiatric disorders (Fukuchi-Shimogori and Grove, [@B9]; Inoue and Krumlauf, [@B14]; Saito and Nakatsuji, [@B37]). Major advantages are the spatial and temporal restriction of gene introduction and the possibility to target more than one gene suitably at different developmental time points. Various constructs, either up- or downregulating the gene of interest, can be microinjected into the lateral ventricles of the developing embryonic brain. The construct is then incorporated into the ventricular surface by electroporation using a series of unipolar square wave pulses, driving expression into specific brain areas in which the position of the positive electrode defines the site of DNA entry (Figure [1](#F1){ref-type="fig"}A). For example, when the positive pole of the electrodes is positioned dorsally of the embryonic forebrain, the electroporated area exist of the more dorsofrontal brain areas such as the hippocampus (Figures [1](#F1){ref-type="fig"}A,B,B′) and prefrontal cortex (PFC; Figures [1](#F1){ref-type="fig"}A,C,C′). More ventrolateral positioning of the positive electrode can specifically electroporate striatal aspects (Figures [1](#F1){ref-type="fig"}A,D,D′). By leaving the embryos undisturbed during further development, the timing of examination can be carefully chosen depending on the question asked. In contrast to the time-consuming generation of transgenic or mutant mouse lines, this method allows for quick analyses of the function of genes in a spatiotemporal manner.

![**Spatial confinement to areas involved in neurodevelopmental disorders using in utero electroporation (IUE) -mediated gene transfer**. **(A)** Schematic representation of IUE into three areas (1) the hippocampus, (2) the prefrontal cortex, (3) the striatum. On the left side, a sagittal view is shown indicating the level of the coronal section (dotted line) shown on the right side where the position of the + and − poles is indicated. IUE is performed at embryonic day 14.5 (E14.5) and embryos are left undisturbed for 4 days *in utero* (diu) before sacrifice (sac) at E18.5. Arrowheads indicate various neurodevelopmental events. **(B)** E18.5 coronal cryosection of an electroporated mouse brain (E18.5--4diu). Control construct CMV--YFP--N1 (green) is electroporated into the hippocampal anlage enlarged in **(B′)** (boxed area), counterstained with the layer V marker Ctip2 (red) and fluorescent Nissl (blue). **(C)** Electroporation was performed into the whole span of the medial prefrontal cortex (mPFC) including the infralimbic (IL), prelimbic (PL), and cingulate cortex (Cg). Boxed area is enlarged in **(C′)**. **(D)** Electroporation was performed into the ventricular zone (VZ) of the caudate putamen (CP) close to the external capsule (EC). Boxed area is enlarged in **(D′)**. CA1, *cornu ammonis 1*; CA3, *cornu ammonis 3*; Cg, cingulate cortex; Ctx, cortex; DG, dentate gyrus; EC, external capsule; Hb, habenula; Str, striatum.](fnmol-04-00037-g001){#F1}

The first major improvement of the technique is the spatial restriction that can be achieved within the developing brain (Figure [1](#F1){ref-type="fig"}). Different areas can be aimed for, depending on the position and/or angle of the positive pole of the electrical square wave current applied (Figure [1](#F1){ref-type="fig"}A). This is an improvement to non-aided *in vivo* viral infections where the infected area is usually large and dependent on the titer (Cetin et al., [@B5]). Areas known to be involved in neurodevelopmental disorders such as the hippocampus (Nakahira and Yuasa, [@B27]; Navarro-Quiroga et al., [@B28]), PFC, and the striatum can now be reached individually and electroporated with the gene construct(s) of interest (Figures [1](#F1){ref-type="fig"}A--D′). In this way, the brain region of interest is affected without disturbing the rest of the embryo. By precisely knocking down a specific gene in only the PFC during development, behavioral abnormalities can be screened postnatally and causal connections can be made with certain endophenotypes that involve working memory or information processing (Gould and Gottesman, [@B13]; Niwa et al., [@B29]). For example, knocking down DISC1, a genetic susceptibility factor in schizophrenia, in the PFC using IUE will lead to particular behavioral deficits in the adult animal (Niwa et al., [@B29]). By targeting the ganglionic eminence or preoptic area, populations of interneurons can be genetically manipulated (Borrell et al., [@B4]; Lopez-Bendito et al., [@B21]; Gelman et al., [@B12]). By specifically labeling sets of interneurons by IUE and manipulating GABAergic circuit formation is a big step forward in neuropsychiatric research as interneurons control the function of cortical networks implicated to be involved in the etiology of neurodevelopmental disorders (Fazzari et al., [@B8]). The dimension of the transfected area can be adjusted by fine-tuning the diameter of the paddle-type electrodes, by using wire-type electrodes and by altering the time between the micro-injection of the DNA and the application of the series of currents. The developmental time point of the micro-injection extends the range of brain areas to be targeted. The retina, for example, can be reached by early micro-injection, with or without facilitation by ultrasound guidance (Garcia-Frigola et al., [@B11]; Punzo and Cepko, [@B34]; Petros et al., [@B32]; Punzo et al., [@B35]). Thus, any brain (sub)area can currently be targeted, including areas more difficult to reach such as the midbrain (Alvarez-Maya et al., [@B1]; Willett and Greene, [@B43]), dorsal thalamus (Bonnin et al., [@B3]), hypothalamus (Gelman et al., [@B12]), amygdala (Remedios et al., [@B36]; Soma et al., [@B38]), or rhombic lip/cerebellum (Kawauchi et al., [@B16]), by manipulating the timing of introduction, the position of the injection and the position of the electrodes.

By manipulating the timing of introduction of the construct of interest (either overexpression or knockdown), various developmental events can be addressed such as proliferation, migration (both radial as well as tangential), axon guidance, dendritic maturation, and synaptogenesis. One of the first studies that used IUE to examine early patterning of the cerebral cortex by Fgf8 was by the lab of Grove (Fukuchi-Shimogori and Grove, [@B9]). Regional patterning was changed such that overexpression of Fgf8 by IUE shifted the position of the somatosensory cortex more caudal, including occasionally the whole barrel field. When progenitor cells are electroporated with plasmids directing the overexpression or knockdown of a target gene, proliferation can be affected which can be tested *in vivo* in combination with the use of BrdU which incorporates into the S-phase of dividing cells (Figures [2](#F2){ref-type="fig"}A,B). For instance, when the forward signaling of the receptor tyrosine kinase EphA4 is diminished in cortical progenitors through IUE by introducing a dominant-negative EphA4 construct lacking the kinase domain, cell division is affected (North et al., [@B30]). Another developmental event that can be studied through the use of IUE is neuronal migration (Figures [2](#F2){ref-type="fig"}C--F). This is particularly apparent in the "inside-out" layering of the cerebral cortex where late-born neurons migrate to their more superficial positions past the early born neurons in the deeper layers. Defects in migration can thus result in aberrant layering or even heterotopias (Kawauchi et al., [@B17]; Bai et al., [@B2]). Using layer-specific markers along with BrdU to "birthdate" cells in combination with IUE, defects in migration can be easily detected (Figures [2](#F2){ref-type="fig"}D--F). Early axon guidance events can be altered by either molecularly changing the target area or the area where the projections originate from (Figures [2](#F2){ref-type="fig"}G,H). Knocking down the levels of Disc1 in a specific subset of pyramidal neurons in the developing mouse PFC actually diminishes the dopaminergic mesocortical projections leading to prominent behavioral problems in adulthood (Niwa et al., [@B29]). Also it was shown that ectopic EphB1 expression in a subset of retinal ganglion cells established using IUE convincingly altered their projection trajectory (Petros et al., [@B33]). Also, the later events in development such as Fgf8 dendritic arborization and connectivity can be studied using IUE (Figures [2](#F2){ref-type="fig"}I,J). The molecular mechanisms underlying late neurodevelopmental events such as synaptogenesis and synapse maturation can be examined by introducing the plasmid early and analyzing the brain areas of interest postnatally (Elias et al., [@B7]). Furthermore, a developmentally very late electroporation paradigm (at E18.5 or postnatal) can be performed and will drive expression in mainly the astrocytic progenitors (LoTurco et al., [@B22]).

![**Temporal restriction of gene introduction during various neurodevelopmental events**. **(A)** Schematic representation of the proliferation paradigm using *in utero* electroporation (IUE). Two hours prior to sacrifice (sac), BrdU is injected to label dividing cells. **(B)** E15.5 coronal section showing the cerebral cortex with in red the BrdU-labeled cells within the proliferative zone (PZ) and in green the CMV--YFP--N1 construct (YFP), counterstained with fluorescent Nissl (blue) 1 day after IUE (1 diu). **(C)** Confocal image of YFP-labeled neurons and radial glia (green) co-stained with the radial glia marker RC2 (red). Arrowhead indicates a migrating neuron "climbing the robe" of a radial glia. **(D)** Schematic representation of the migration paradigm using IUE. Just after surgery BrdU is injected to label dividing cells and "birthdate" them. **(E)** E17.5 coronal section showing the cerebral cortex with BrdU-labeled cells (red) that have migrated to a certain position within the cortical plate (CP) combined with a YFP control construct (green), counterstained with fluorescent Nissl (blue) 3 days after IUE (3 diu). As soon as the YFP-positive neurons become post-mitotic they start to migrate and can be double labeled with BrdU (yellow). **(F)** Is an enlargement of the boxed area in **(E)**. **(G)** E18.5 coronal section showing an YFP-labeled (green) somatosensory cortex (S1) projecting toward the other hemisphere through the corpus callosum (CC) counterstained with superficial layer marker Satb2 (red) and fluorescent Nissl (blue). **(H)** Is an enlargement of the projections through the CC in **(G)**. **(I)** P24 coronal section showing YFP-positive pyramidal neurons (green) in layer IV of the S1 on top of the layer V marker Ctip2 (red). **(J)** Network formation of YFP-positive pyramidal neurons with extended dendritic branches and axonal projections. Counterstained with Ctip2 (red) en fluorescent Nissl (blue).](fnmol-04-00037-g002){#F2}

To manipulate gene expression, constructs can be designed to target specific cells at a specific time (Miyagi et al., [@B25]; Gal et al., [@B10]; Wang et al., [@B42]). Experiments using IUE can be performed using either knockdown by RNA interference (RNAi), antisense morpholinos, dominant-negative (DN; North et al., [@B30]) constructs, or toxins (Wang et al., [@B41]) to manipulate cell signaling, or a Cre--Lox system to fine-tune expression time or combinations of constructs in which a full-length (FL) version is later used to rescue a particular phenotype (Mizutani and Saito, [@B26]; Matsuda and Cepko, [@B24]). The high capacity and efficiency of viral vectors makes them suitable for the overexpression of large full-length constructs but can however elicit immune responses in the adult brain (Davidson and Breakefield, [@B6]; Cetin et al., [@B5]). The downside of non-viral vectors on the other hand is that they are expected to be preserved episomally and thus not suitable for lineage trace experiments. Promoters such as the cytomegalovirus (CMV) and elongation factor 1α (EF1α) are not cell-type-specific and yield moderate expression levels that persist after birth and can therefore be used to study various developmental events (Figure [3](#F3){ref-type="fig"}). A battery of fluorescent elements can be either incorporated into the construct or co-electroporated with another construct to visualize the expression pattern (Figures [3](#F3){ref-type="fig"}A,B). Nowadays the most commonly used knockdown construct is the micro-RNA30-based short hairpin RNA (shRNA) for RNAi under the ubiquitous polymerase II promoter like chicken actin (CAG; Figure [3](#F3){ref-type="fig"}C). The knockdown of doublecortin-like (DCL) for example resulted in a reduced proliferation of neurons and radial glia fiber instability (Vreugdenhil et al., [@B40]). Distinct neurodevelopmental events in a subset of neurons within a particular region can now be controlled using cell-type-specific regulatory elements (Matsuda and Cepko, [@B24]; LoTurco et al., [@B22]; Manent et al., [@B23]). Cell-type-specific promoter or regulatory elements such as Thy1, Nestin, Tα1, BLBP, PDGF, GLAST (Gal et al., [@B10]), CAMKII, Synapsin, DCX (Wang et al., [@B42]), NSE but also ER81 and Ngn2 (Langevin et al., [@B19]) can drive expression of a fluorescently labeled construct into a particular neuronal cell population in which the time of expression can be both dependent on the time of electroporation and the period of expression of the regulatory element (Figure [3](#F3){ref-type="fig"}A). In this way endophenotypes can be further unraveled because of the specificity of the gene manipulation. To dissect gene--gene interaction, multiple constructs of different genes can be electroporated at the same time which is again a great step ahead in deciphering the molecular pathways underlying cognitive deficits associated with neurodevelopmental disorders (Kamiya, [@B15]). Neuronal migration is often affected in these disorders and Young-Pearse et al. ([@B44]) showed that the effect on migration, by knocking down APP and Dab1, could be later recued using overexpression of Dab1. Likewise, when RNAi of Lis1 and dynein mutants where expressed at the same time their dual role in neuronal migration could be unraveled (Tsai et al., [@B39]).

![**Constructs for use in *in utero* electroporation (IUE) to direct expression in a four-dimensional way**. **(A)** Schematic representation of the most frequently used constructs that can be constitutively expressed under either a ubiquitous promoter (e.g., CMV, cytomegalovirus; EF1, elongation factor 1; ROSA, ROSA26 TATA-less promoter; CAG, chicken actin combined with CMV enhancer) or a cell-type-specific promoter (e.g., Thy1, THYmocyte differentiation antigen 1 driving expression in axons of neurons; Nestin, neuronal stem cell tubulin neuronal promoter; Tα1, α-tubulin neuronal promoter; BLBP, brain lipid-binding protein radial glial specific promoter; GLAST, glutamate--aspartate transporter radial glial/astrocytic promoter; CAMKII, calcium/calmodulin-dependent kinase II neuronal promoter specific for forebrain; Synapsin, neuronal promoter; DCX, doublecortin neuroblast-specific promoter; NSE, neuron-specific enolase drives expression in neurons and to some extent in glial cells; ER81, ETS family transcription factor driving expression in specific subset of neurons; Ngn2, neurogenin2 driving expression in neurons; TH, tyrosine hydroxylase dopaminergic neuron-specific promoter). These promoters can drive expression of among others full-length (FL) constructs, dominant-negative (DN) constructs or, e.g., shRNAs of genes of interest (GOI) to establish knockdown via RNAi. The reporter element can be either a fluorescent protein ranging from far red, red, orange, yellow, green, or cyan fluorescence or LacZ. Often enhancer elements (e.g., SV40, NFkB, NFAT, ISRE, or p53) are used, but this is not always essential to drive the expression. Electroporation constructs are all terminated with a polyA tail. **(B)** Schematic representation of the commonly used inducible constructs such as the Cre-reporter construct expressed under an ubiquitous or a cell-type-specific promoter. The GOI containing construct can be under the control of an ubiquitous promoter (usually CAG) a neomycin (neo)-cassette that is floxed (loxP before and after) and thus excised upon addition of tamoxifen at a specific time point in development. **(C)** Example of a knockdown experiment using IUE with an off-target construct (control) and RNAi against the doublecortin-like gene (pSuper-DCL183 or DCLi). Both in the proliferative zone (PZ) as well as in the intermediate zone (IZ) and cortical plate (CP) neurons are reduced in number and the radial fibers are severely disrupted. Green is the construct, red is a β-tubulin staining (Tuj1). Adapted from Vreugdenhil et al. ([@B40]).](fnmol-04-00037-g003){#F3}

Inducible models generated through the use of IUE have opened a new dimension to study the complexity of gene function(s) in the development of brain areas. The Cre--LoxP system can be used in combination with the ubiquitous CAG promoter or with above-mentioned regulatory elements that will allow expression in only a subset of neurons in a particular area and in a specific, carefully chosen time window through administration of tamoxifen inducing the Cre--ER(T) recombinases (Figure [3](#F3){ref-type="fig"}B). In this way, the onset of gene expression/suppression can be manipulated, for example at the peak of postnatal synaptogenesis avoiding the effect of this particular gene targeting on earlier events like neurogenesis or migration (Mizutani and Saito, [@B26]). Such an inducible system can furthermore be used in conjunction with the formerly performed effective RNAi-based knockdown where a possible rescue can be put in place postnatally (Matsuda and Cepko, [@B24]).

Together, IUE-mediated gene transfer has shown to be an exceptional powerful tool to create animal models in which both the spatial as well as the temporal aspects of gene expression can be manipulated. In future studies, adjustments like different sizes and shapes of the electrodes will further enhance the ability to specifically target a (sub)area. Inducible systems using chemical agents or optogenetic light-sensitive constructs such as channel-or halorhodopsin-assisted IUE (Petreanu et al., [@B31]; Lewis et al., [@B20]; Zhang et al., [@B45]) will further restrict the expression window in space and time, and thus a more precise control of gene manipulations can be achieved. Combined with the use of constructs containing regulatory elements that drive expression in not only a temporally way but also in an area-, layer-, and neuronal cell population-specific manner will greatly enhance our knowledge of the functions of particular susceptibility genes playing a role in brain area-specific cognitive deficits associated with neurodevelopmental disorders.
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